Komori
Earnings3762TECHMATRIX CORPORATIONInformation and Communications, Services and Others

Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [IFRS] (Consolidated)

For the interim period of the fiscal year ending March 2027, revenue, operating profit, profit before tax and interim profit attributable to owners of the parent all exceeded the same period of the previous year, each reaching a record high for an interim period. The full-year earnings forecast remains unchanged, while the annual dividend forecast has been revised to ¥56.

Worth reading
58In focus
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
16.8
% (year-on-year increase in revenue)
Wording
Conditional
How definitive the wording is.

Results for this period

Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedIFRS
Net Sales38,999¥ millionYear on year +16.8%Progress 47.7%
Operating profit3,507¥ millionYear on year +10.5%Progress 42.8%
Ordinary income3,569¥ millionYear on year +11.5%Progress 43.1%
Net income attributable to owners of the parent2,373¥ millionYear on year +12.7%Progress 44.1%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥59.14
Financial position at period-end
Total assets128,060¥ million
of which net assets 32,909 ¥ millionEquity ratio 20.6%vs. prior year-end -1.1pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash and cash equivalents at end of period27,313,091 thousand yen
Segment revenueInformation infrastructure business 28,872,835 thousand yen (YoY +19.2%), Application and services business 5,458,642 thousand yen (YoY +15.7%), Medical Systems Business 4,668,257 thousand yen (YoY +5.3%)
Segment profitInformation infrastructure business 3,220,582 thousand yen (YoY +10.0%), Application and services business 206,893 thousand yen, Medical Systems Business 80,470 thousand yen (YoY -73.3%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥81,800 million (YoY +14.0%)
Operating profit¥8,200 million (YoY +5.7%)
Ordinary income¥8,280 million (YoY +5.3%)
Net income¥5,380 million (YoY +3.9%)
Annual Dividend Forecast52 yen → 56 yen(+7.7%)
Factors Behind Changes in Business Performance

Revenue increased due to growing demand, particularly for cloud-based security products, the accumulation of new projects and renewal orders, the accumulation of subscription contracts, and an increase in the number of medical facilities contracted for medical systems, together with accumulated subscription revenue. Operating profit was supported by growth in the information infrastructure business, which absorbed the increase in selling, general and administrative expenses driven by higher personnel costs and other factors. In the medical systems business, the investment phase of メドメイン株式会社 had a negative impact on operating profit.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 Not disclosed
Changes in the scope of consolidationNew 1 / Name of newly included company Medmain Co., Ltd. / Excluded 0 / Excluded Company Name Not disclosed
Material subsequent eventsNone
Orders received and order backlogOrders received Information infrastructure business 41,651 / Application and services business 5,969 / Medical Systems Business 6,124 / Total 53,745 / Order backlog Information infrastructure business 91,659 / Application and services business 7,636 / Medical Systems Business 20,966 / Total 120,262
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts)
Issued Shares at Period-End44,518,400
Treasury Shares at Period-End4,736,877
Results for this period
ItemDetails
Fiscal Period ClassificationInterim period (second quarter)
Accounting standardsIFRS
Consolidated / non-consolidatedConsolidated
Period Covered1 April 2026 to 30 September 2026
Net Sales¥38,999 million (YoY +16.8%)
Operating profit¥3,507 million (YoY +10.5%)
Ordinary income¥3,569 million (YoY +11.5%)
Profit attributable to owners of the parent¥2,373 million (YoY +12.7%)
Net income per share¥59.14
Equity ratioEnd of the current fiscal period 20.6 / End of previous period 21.7
Total assets¥128,060 million
Net assets¥32,909 million
Cash and cash equivalents at end of period27,313,091 thousand yen
Full-year earnings forecastNet Sales ¥81,800 million (YoY +14.0%) / Operating profit ¥8,200 million (YoY +5.7%) / Ordinary income ¥8,280 million (YoY +5.3%) / Net income ¥5,380 million (YoY +3.9%)
Annual Dividend Forecast52 yen → 56 yen(+7.7%)
Segment revenueInformation infrastructure business 28,872,835 thousand yen (YoY +19.2%), Application and services business 5,458,642 thousand yen (YoY +15.7%), Medical Systems Business 4,668,257 thousand yen (YoY +5.3%)
Segment profitInformation infrastructure business 3,220,582 thousand yen (YoY +10.0%), Application and services business 206,893 thousand yen, Medical Systems Business 80,470 thousand yen (YoY -73.3%)
Orders received and order backlogOrders received Information infrastructure business 41,651 / Application and services business 5,969 / Medical Systems Business 6,124 / Total 53,745 / Order backlog Information infrastructure business 91,659 / Application and services business 7,636 / Medical Systems Business 20,966 / Total 120,262
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed
Changes in the scope of consolidationNew 1 / Name of newly included company Medmain Co., Ltd. / Excluded 0 / Excluded Company Name Not disclosed
Material subsequent eventsNone
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts)
Issued Shares at Period-End44,518,400
Treasury Shares at Period-End4,736,877
Factors Behind Changes in Business PerformanceRevenue increased due to growing demand, particularly for cloud-based security products, the accumulation of new projects and renewal orders, the accumulation of subscription contracts, and an increase in the number of medical facilities contracted for medical systems, together with accumulated subscription revenue. Operating profit was supported by growth in the information infrastructure business, which absorbed the increase in selling, general and administrative expenses driven by higher personnel costs and other factors. In the medical systems business, the investment phase of メドメイン株式会社 had a negative impact on operating profit.
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesDepreciation and amortizationImpairment lossBreakdown of extraordinary income (loss)

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue increased due to growing demand for cloud-based security products, the accumulation of new projects and renewal orders, and growth in subscription contracts and recurring revenue from medical systems. Selling, general and administrative expenses increased due to higher personnel costs and other factors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [IFRS] (Consolidated) | TECHMATRIX CORPORATION (3762) timely disclosure | Komori